The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
ESCCAP says that the risk of novel parasites and zoonoses spreading to new regions has risen alongside an increase in pet travel and changing climate conditions.
ESCCAP’s Guideline 09 offers detailed advice on how to protect dogs and cats that travel or are imported across European borders, minimise the risk of zoonotic transmission and prevent the establishment of new parasites in previously unaffected areas.
Topics covered in the guideline include:
The guideline emphasises the importance of early detection of parasitic infections by thorough clinical examinations, comprehensive travel history assessments and targeted diagnostic testing.
It also provides guidance on educating pet owners about zoonotic risks and implementing appropriate treatments and follow-up screenings.
www.esccap.org/guidelines/gl9/
Vet-AI's automated triage app offers instant advice to pet owners 24/7, early detection of health issues and advice as to whether they need to speak to a vet.
For the blinded test, which was conducted in April 2025, three UK veterinary surgeons reviewed the responses from Vet-AI, Gemini 2.0 and ChatGPT 4.0 to 48 simulated enquiries from owners.
The vets evaluated each on clinical accuracy, triage effectiveness and the subjective criteria of factuality, integrity, safety, empathy and readability.
Vet-AI’s Large Language Model (LLM) achieved an accuracy score of 81%, surpassing Gemini (69%) and ChatGPT (50%).
Vet-AI’s model also stopped triage at the correct point in 81% of cases according to the vets, compared with Gemini’s 75% and ChatGPT’s 56%.
Vet-AI’s tool also outperformed the leading LLMs on subjective measures, delivering more empathetic, thorough and factual responses to pet owners.
Samantha Webster, Chief Veterinary Officer at Vet-AI said: “These latest results are a significant milestone in the development of automated triage.
"We’re proving we can provide trustworthy online pet care by combining clinical and technical expertise.
"This tool can support the wider industry too, engaging more pet owners in the first step of vet care, ensuring their pets get the care they need - whether in practice or remotely.
"We know that an increasing percentage of the UK pet population is struggling to access veterinary care.
"Whilst AI will never replace a vet, the use of innovative technology can break down the barrier to access, leading to more pets getting the care they need, when they need it."
“With this level of clinical accuracy and technical innovation, we're helping to bring great pet care to more people. As well as helping to create more demand for vet services by making the triage of pets as accurate as possible,” said Paul Hallett, Vet-AI founder and exec chair.
https://www.vet-ai.com/automated-triage
Presented by The Webinar Vet and Vet Dynamics, the Vet Trust Awards celebrate notable contributions to veterinary advancement.
Claire Towers, General Manager of Hill’s Pet Nutrition UK and Ireland said: “Our recognition as the most trusted pet food brand is a testament to the unwavering dedication of the Hill’s team, ensuring vets remain integral to our mission.”
The March 2025 Cattle Highlights Report from the Royal GD in the Netherlands has revealed that the proportion of paromomycin-resistant isolates has jumped from 48% in 2021 to 72% in 2024.
The report also highlights an increase in the detection of cryptosporidiosis in calves up to 14 days of age.
MSD says that while it is unclear whether paromomycin is being used to treat E.coli or cryptosporidiosis, the rising use of the antibiotic could be contributing to greater exposure and increased resistance in E.coli K99.
Kat Baxter-Smith MRCVS (pictured), a vet advisor at MSD Animal Health, said: “What we need now is a mindset shift—moving away from routine antibiotic use and towards a more robust, preventative management strategy.
“It’s not about eliminating treatment altogether but using it only when it is really needed.”
“Vaccination, clean pens, and ensuring that every calf receives the right volume and quality of colostrum are the real cornerstones of effective scour control.
“Using vaccines such as Bovilis Rotavec Corona for rotavirus, coronavirus, and E.coli and Bovilis Cryptium for Cryptosporidium parvum is one of the most effective ways to reduce the incidence of neonatal diarrhoea.
"By vaccinating the dam, we ensure the calf has the best possible immunity at birth by ingesting the fortified colostrum and transition milk in the first days of life, which significantly reduces reliance on antibiotics and minimises disease risks.”
The report emphasises best-practice principles such as effective colostrum management, good hygiene and housing, balanced dry cow transition and strategic vaccination of the dam.
The report also recommends halofuginone (Halocur) as the first-line treatment for cryptosporidiosis, due to its targeted action and significantly lower risk of contributing to AMR.
Kat added: "By embracing these proactive strategies, vets and farmers can take a crucial step towards safeguarding calf health, reducing reliance on antibiotics, and combating the growing threat of antimicrobial resistance.”
https://issuu.com/gezondheidsdienstvoordieren/docs/highlights_report_cattle-march_2025
The factsheets, which cover canine chronic bronchitis, feline asthma and equine asthma, are designed to help explain complex conditions more effectively, encourage earlier diagnosis, and improve treatment compliance.
The downloadable factsheets can be printed, emailed to clients, or displayed in waiting areas and on waiting room screens.
Jon Slattery MRCVS, Director of BreathEazy, said: “We often see a seasonal spike in respiratory cases at this time of year, particularly in animals with underlying conditions.
"Having owners on board and confident in managing their pet’s condition is a key part of treatment success.
"These factsheets offer a time-saving way for vets and nurses to educate clients, reinforce advice given in consults, and help owners understand how to support their pets at home.”
https://mailchi.mp/breatheazy/resourcedownload
www.breatheazy.co.uk
The guide is aimed at established practices, new start-ups and those who may be thinking about setting up a practice.
It includes practical information, videos and first hand advice from independent practice leaders who are members of Vetsure and who've successfully navigated the challenges of practice ownership and management.
In the book, Diane Storer of Cockburn Vets offers tips for recruiting and building a collaborative team, whilst Julie Hutton of Hilltop Vets shares her thoughts on leadership and addressing practice challenges.
Other contributors to the guide include Vicki Farbon of Scott Veterinary Clinic, Kate Hornby of Wild Side Vets, Emily Nightingale of Nightingale Vets and Simon Hayes of Creature Comforts, who draw from their diverse experiences of founding and operating independent practices.
Ashley Gray, Managing Director of Vetsure said: “The insights from successful independent practice owners and Vetsure network members included in the guide offer lessons from real experiences beyond generic business courses."
He added: “The Vetsure network aims to support and champion independent veterinary practices by sharing knowledge and expertise, facilitating learning from fresh perspectives and ideas, and fostering genuine collaboration,”
https://www.vetsurevet.com/guide-to-success
To mark the end of his presidential year at BSAVA, Julian will be strapped to the top of a vintage biplane while dressed in a full feline (Cheshire Cat) costume, to support the research that BSAVA PetSavers funds to improve the health and wellbeing of pets across the UK.
BSAVA PetSavers is one of the UK’s few funding bodies focused solely on clinical research into diseases affecting companion animals.
To date, it has invested more than £2.7 million in vital studies addressing conditions such as cancer, heart disease, neurological and joint disorders, gastrointestinal issues.
Julian said: "Every day, vets face the heart-wrenching task of managing the distress and pain our pets suffer due to disease or poor health.
"With your support, we can ensure that they have access to the latest knowledge and resources needed to provide the best care possible.
“The need for advanced research is more pressing than ever and our pets deserve every chance at a healthy life.
"If dressing up as a cat and flying on the wing of a plane makes people take notice of the vital need for pet health research, then it will be worth it.”
Alison Selby, Fundraising Manager for BSAVA PetSavers said: “No one has ever been quite so daring in their fundraising efforts for us, so we are thrilled that Julian has decided to take this on to raise awareness and funds for BSAVA PetSavers.
“For every grant application that we fund, at least two or more are declined due to lack of funds. Fundraising events like this helps to land more funding in the hands of researchers who make a real difference in the veterinary community and directly impact the lives of countless pets and their families.”
Julian’s wing walk is on the 29th May and his target is to fundraise £1,000.
https://www.justgiving.com/page/julian-hoad-2
The company says the webinar, presented by Dechra veterinary technical advisor, Emily Casey BVM&S MRCVS (pictured), will save vets' time and enhance their canine patients’ quality of life.
Emily said: “Canine Cushing’s syndrome can seem over-complicated, and we receive about 200 calls a month on the disease, so we’ve seen it all.
"Our new webinar will provide vets with a straightforward, no-nonsense approach to Cushing’s that will transform how they manage their next canine Cushing’s case.”
Delegates who join the webinar live will be entered into a prize draw to win a Littman Classic III Stethoscope.
https://go.dechra.co.uk/3-things-about-cushings
Super early bird tickets are available till 28th May.
Rose’s programme recommendations are:
BEVA Congress programme will be embracing the overarching theme of “use it wisely or lose it forever”, chosen by BEVA President Bruce Bladon.
Bruce said: “Antibiotics is an issue which goes so far beyond equine practice and is one of the genuine threats to humanity.
"We must use these precious and finite resource wisely, or, quite reasonably, regulators will prevent us having access to them.
“But this theme resonates further, to the “social licence” which threatens the future of equine sport.
"Rather than platitudes about horse welfare, we now need to show the positive steps we can take to minimise equine injury.
"We need to be developing screening programmes and to be instrumental in safety programmes.
"Otherwise, we may lose equestrian sport forever.”
Individual super early bird BEVA members prices for a three-day pass are £539 for vets for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Super early bird ends on 28 May 2025.
http://www.bevacongress.org
The map gives an overview of the regulation applying to virtual care in different countries and it shows how virtual veterinary care is regulated predominantly in Western European countries only.
For the countries where veterinary virtual care is subject to regulation, the new map shows which countries:
https://vvca.org/resources/europe
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
Reference
The award, which is sponsored by Zoetis, celebrates vets in the first eight years of their career who have shown outstanding care, dedication or success.
Nominees may have delivered exceptional care to a patient, made a positive contribution to their community or the wider veterinary profession, or shown their dedication to a cause.
Early career vets who are keen to demonstrate their ambition and dedication to the profession can also self-nominate for the award.
British Veterinary Association President Elizabeth Mullineaux said: “We know how hard all vets work to care for the UK’s animals and to protect both human and animal health and welfare.
"Our young and early career vets deserve to have their incredible work recognised and this award is an opportunity to highlight their compassion, skills and positive contribution to the profession.”
The winner will be announced on Thursday 16th October 2025 at the BVA Awards in London, where they will be awarded a prize package which includes £1,000, a year of free BVA membership and mentoring/engagement opportunity with Zoetis.
The deadline for entries is 9am on Monday 4th August 2025.
www.bva.co.uk/YVOTY
Photo: Last year's winner, David Charles.
The study is being conducted with pet owners and veterinary professionals to develop a greater understanding about how flea and tick treatments are used on cats and dogs.
It will involve two depth surveys to explore the type and format of treatments used, the frequency of application, where treatments are bought, what influences the choice of product, whether there is an awareness of ectoparasiticides’ environmental effect and what preventative steps the public and clinicians would take when using the treatments on animals in the future.
At a later stage, the research project will also include lab assessments of ectoparasiticide residues collected from companion animals to provide more information on their potential environmental impact.
It is hoped the research findings will help the veterinary profession develop the most appropriate approaches to ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’.
Project leader Professor Richard Wall from the University of Bristol, said: “This is an issue of considerable concern.
"Citizen science and laboratory research evidence is urgently needed so that risk-based assessments of the impact of and requirements for ectoparasite treatment can be made.
"Whilst we can make some assumptions around the impact of routine ectoparasite treatments, these findings are essential for us to truly understand them - and to be able to balance the needs of veterinary patients with their wider environmental impacts.”
https://forms.office.com/e/mbztbYf4Ru.
The Health Products Regulatory Authority (HPRA) has also granted a marketing authorisation in exceptional circumstances (Article 25, 26 EU Reg 2019/6) for Bultavo 3 in Ireland.
The company says that so far, more than 40 million doses of Bultavo 3 have been distributed in Europe to help limit the spread of BTV-3.
Boehringer points to a recent field study published by the German reference laboratory Friedrich-Loeffler-Institut (FLI), which showed that vaccination of sheep and cattle with Bultavo 3 induces immunity against the virus1.
According to the study, animals vaccinated with Bultavo 3 consistently showed evidence of a protective antibody response to BTV-3, although animals vaccinated with other BTV-3 vaccines did not1.
Boehringer says it is now compiling the data needed to obtain a full marketing authorisation in accordance with Article 8 of EU Regulation 2019/6.
Bravecto Triuno is approved for the treatment of tick and flea infestations in dogs (Ctenocephalides felis, C. canis, Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus, and Rhipicephalus sanguineus).
It is also approved for the treatment of infections with roundworms (adult stages of Toxocara canis and Toxascaris leonina) and hookworms (L4, immature adult (L5), and adult stages of Ancylostoma caninum and Uncinaria stenocephala), for the prevention of heartworm disease (caused by Dirofilaria immitis), and for the prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).
Victoria Miles, UK Companion Animal Director, MSD Animal Health, said: “With this latest formulation of Bravecto, MSD Animal Health is giving veterinarians and dog owners a greater range of convenient options for protecting their dog year-round from parasites, and all from the same trusted Bravecto portfolio.”
She added: “We see Bravecto Triuno as a great option for puppies that require a monthly wormer on top of protection against fleas and ticks.
"This also gives flexibility later on for the dog to remain with the Bravecto brand but be swapped onto a longer-duration flea and tick product with a wormer administered according to a veterinarian’s risk-based assessment.”
Bravecto Triuno is available as a flavoured chewable tablet indicated for dogs and puppies from 8 weeks of age and at least 1.27 Kg body weight and can be administered monthly to dogs at risk of infestation by multiple types of internal and external parasites.
It contains three anti-parasitic ingredients including fluralaner, which provides activity against ticks and fleas, moxidectin, which provides systemic activity against non-intestinal worms, and pyrantel, which provides activity against intestinal worms.
https://www.noahcompendium.co.uk/?id=-488423
Mr Georgescu faced three sets of charges:
The first was that in April 2024 at Newcastle Magistrates’ Court, he pleaded guilty to driving a car when the proportion of the controlled substance Benzoylecgonine (the main metabolite of cocaine) exceeded the specified limit contrary to the Road Traffic Act 1988 and the Road Traffic Offenders Act.
He was disqualified from driving for 20 months, fined £634, ordered to pay £254 victim surcharge and £150 costs.
The second and third charges were that he was misleading and/or dishonest with the RCVS when he was asked to provide information about the circumstances leading to his conviction.
In correspondence with the College, he claimed that the incident happened on his day off, when he was in fact due to work that day.
He also submitted – or allowed to be submitted – a false staff rota for the day of his arrest.
The Disciplinary Committee found the charges against Mr Georgescu proven on the basis of the certificate of conviction and his admission, prior to the hearing, that he had given false information.
The Committee then considered whether the three charges amounted to serious professional misconduct.
The Committee considered the fact that Mr Georgescu was driving, and intending to work, while he was seven times over the prescribed proportion of Benzoylecgonine allowed to be in in his bloodstream.
Paul Morris, chairing the Committee and speaking on its behalf, said: “With regard to the impact this conduct would have on right thinking members of the public, Dr Georgescu himself said, when cross examined, that were he standing in the shoes of an owner of an animal he was going to treat that day with the knowledge that he had in his blood more than 7 times the prescribed limit of a prohibited drug he “would not be comfortable for sure” and would cause such persons to “lose trust”.
“Having regard to the above facts and matters the Committee has no hesitation in concluding that the facts relevant to his commission of the offence in Charge 1 were so serious and presented such prospective risks to other road users that it renders the respondent unfit to practise as a veterinary surgeon.”
Charges 2 and 3 were considered together, with the Committee again finding serious professional misconduct on the basis that Mr Georgescu had set out to lie to the RCVS and had continued and repeated the lie for a period of six months.
The Committee identified a number of aggravating features in his conduct including the fact it was premeditated, entailed sustained and repeated dishonesty, involved wilful disregard for the role of the RCVS as the veterinary regulator and that admissions were only made when he realised he couldn’t sustain his falsehoods any longer.
Finally, having found that all charges were proven and amounted to serious professional misconduct, the Committee decided that suspending Mr Georgescu from the Register of Veterinary Surgeons would be adequate to protect the welfare of animals, maintain public confidence in the profession, and declare and uphold proper standards of conduct.
Paul Morris added: “The misconduct of the respondent is serious but his misconduct falls short of being fundamentally incompatible with remaining on the Register.
"He does have insight into the seriousness of his misconduct and there is, in the judgement of the Committee, no significant risk of repeat misleading behaviour.
"The Committee also considers that the respondent will be fit to return to practice after the period of suspension in question.
“The Committee did consider striking the respondent from the Register but determined that this sanction would be unduly punitive and deprive the public and the profession of an otherwise competent veterinary surgeon.
“The Committee has reflected carefully on the question of how long the period of suspension should be and has determined that it should be a period which is not so long that it will result in the loss of the respondent to the profession which he professes to love and in which his referees assert he is a capable and caring veterinary surgeon.”
www.rcvs.org.uk/disciplinary
The VetCompass database now holds millions of anonymised veterinary clinical records collected from primary practices and referral centres across the UK.
The records allow researchers to investigate a range and frequency of companion animal health problems and identify important risk factors for the most common disorders.
This research can then be used by veterinary professionals in clinical practice to help improve education and outcomes related to animal welfare.
Dan’s nomination included recognition for VetCompass operating under non-profit and open-access principles and embedding mandatory welfare pathways into all studies.
VetCompass was also recognised for having supported more than 140 research papers supporting broad welfare initiatives spanning breed-related health, extreme conformations, welfare scoring, specific disorders, oncology, disease surveillance, prescribing practices, and more.
Dan said: “I am truly humbled to receive this recognition from the RCVS.
"When I moved from clinical practice to the RVC 15 years ago to develop VetCompass as my PhD project, I could only dream of the untapped potential for practising veterinary surgeons and veterinary nurses to contribute to cutting edge science and welfare.
"And now the amazing VetCompass team at the RVC have made that aspiration to redefine the clinical evidence base on companion animal welfare a reality.
"I now need to reset even higher animal welfare dreams for the next 15 years.”
https://www.rvc.ac.uk/vetcompass/about/overview
The extension, which does not collect any data, interrupts searches related to a broad range of mental health and life challenges, including substance misuse, financial struggles, eating disorders, domestic abuse and more, with a positive message of hope and signposts to a variety of different mental health services.
According to R;ipple, its extension has now interrupted over 100,000 harmful online searches and 32 people so far say they are still alive today because the software intervened at a moment of crisis.
Nick Berryman from Agilio said: “Our commitment aligns with R;pple's mission to combat the stigma surrounding mental health and provide essential resources for those at risk.
"As part of this, we have implemented the tool across our own organisation to safeguard the wellbeing of our staff.
"In parallel, by supporting R;pple’s wider initiatives, we are helping to raise awareness and empower healthcare communities to take proactive steps in supporting those in need.”
R;ipple will be holding a live webinar on Tuesday 7th May at 1pm: Supporting workplace mental health and suicide prevention: my brother’s legacy.
In the webinar, R;ipple founder Alice Hendy MBE will draw on her experience of having lost her brother, Josh, to suicide in 2020 at the age of 21, and explain how healthcare organisations can create safer, more supportive environments through practical steps and awareness.
To register to attend, visit https://tinyurl.com/my-brother-s-legacy.
https://www.ripplesuicideprevention.com
https://agiliosoftware.com/
606 veterinary professionals took part in the research, mostly Practice Managers (34%), Head Nurses (23%) Head Vets (22%) and Administrators (9%)
Of all the respondents, which included those newly-promoted, early career, middle management, senior management and principal leaders, 33% of respondents described their competence as ‘intermediate’, 47% as intermediate, 18% as 'advanced' and only 2% as ‘expert’.
The VMG says its report raises fresh concerns about the preparedness of those tasked with steering veterinary teams through an increasingly complex and demanding landscape.
Rebecca Robinson MRCVS (pictured), incoming VMG President, said: “This year’s report again highlights the urgent need to equip both current and future leaders with the skills and support they need to thrive.
"While there are encouraging signs of progress, we must act with greater urgency as a profession to embed leadership development at every level - especially for those stepping into leadership roles for the first time."
“We encourage all members of the veterinary team to invest in developing their communication and influencing skills well before they take on leadership roles.
"Gaining experience in these areas early on will better prepare them for the demands of leadership and empower them to take charge of their career journeys.
“We also call on employers to make leadership development a priority."
The VMG offers a range of Institute of Leadership and Management-accredited qualifications – the Award, Certificate and Diploma in Veterinary Leadership and Management.
https://vetmg.com/qualifications/cvlm/
The survey, which takes about three minutes, will assess horse owners’ experiences of strangles and includes questions on the disease including preventative measures and vaccination.
There will be a prize draw from completed entries and the winner will get two VIP tickets to Your Horse Live 2025.
Rachel Harrison-Osborne MRCVS, equine field manager at Dechra said: “The strangles survey will provide us with a valuable insight into horse owners’ experiences of the disease and will enable us to identify any trends that may exist to help us support owners who wish to put in place preventative measures to help prevent strangles.”
https://forms.office.com/e/85gzEd7J7A
Photo: Redwings Horse Sanctuary
The researchers’ objective was to determine whether dogs with intracranial space occupying lesions (iSOLs) on MRI, or MRI-determined indicators of intracranial hypertension (ICH) had higher sedation scores with a more rapid onset of recumbency after the administration of IV butorphanol than dogs without intracranial disease.
They hypothesised that 0.2 mg kg-1 of butorphanol administered intravenously would result in statistically significantly higher sedation scores and quicker onset of recumbency in dogs with MRI-iSOL and MRI-ICH.
For the observational study: 'The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension', 53 dogs presented for a brain MRI.
Each dog was sedated with 0.2 mg kg-1butorphanol IV, and the quality of sedation and the onset of recumbency were scored before drug administration and every 5 minutes after administration for 15 minutes using a modified sedation scale.
The maximum sedation score was 18, and onset of recumbency was recorded when a dog lay down without the ability to stand.
Dogs with MRI-iSOL had significantly higher median sedation scores than dogs without MRI-iSOL (12 versus 5 respectively) 15 minutes after butorphanol administration (T15, p < 0.01).
A greater number of dogs with MRI-ICH achieved recumbency (n = 9/10; 90%) than those without MRI-ICH (n = 20/43; 46.5%; p = 0.01).
Emma Sansby, Resident in Anaesthesia and Analgesia at Lumbry Park Veterinary Specialists, who led the research, said: “When intracranial disease is suspected, the administration of butorphanol as a premedicant for anaesthesia could be used to predict the presence of MRI-iSOL and MRI-ICH.
"If a dog becomes recumbent or has a sedation score of more than 10 within 15 minutes of butorphanol administration, the animal should be treated with an anaesthesia protocol adapted to the presence of ICH – so as not to increase intracranial pressure.
“These adaptations include but are not limited to; adequate preoxygenation - to prevent hypoxaemia and elevation of the head to no more than 30 degrees; preventing increases in central venous pressure - by avoiding jugular compression and avoiding excessive intraabdominal and intrathoracic pressure; and a smooth anaesthetic induction - ensuring an adequate depth of anaesthesia prior to tracheal intubation to prevent the cough reflex and judicious mechanical ventilation to enable a low-normal end-tidal carbon dioxide.”
Photo: www.depositphotos.com
Undertaken in practice, industry and academia, submissions are open each year offering the chance to present a Clinical Abstract, presented as a poster or an oral presentation.
Christine Pye won the Medicine Award for her longitudinal study of age, sex and health-related changes in physical biomarkers in pet cats
Alberto Sesana won the Surgery Award for his abstract: "Outcome of lip-to-lid subdermal plexus flaps to reconstruct defects of the lower eyelid in dogs and cats: 46 cases (2005-2022)."
Deborah Komianos won the Practitioner Award for "Reducing use of critically important antibiotics: A clinician-led improvement project across 21 UK small animal veterinary practices."
Rosemary Perkins won the Poster Award for: "Swimming emissions from dogs treated with spot-on fipronil and imidacloprid: assessing the environmental risk."
Lastly but not leastly, Claudia Franzini won the Student Award for: "Does the surgical method for management of Cranial Cruciate Ligament Rupture in dogs affect clinical outcome?"
Submissions for the 2026 Clinical Abstracts will open on 8th September 2025.
https://www.bsavacongress.com
Photo: L-R, Alberto Sesana, Deborah Komianos, Christine Pye, Rosemary Perkins, Claudia Franzini
The Swadlincote and Melbourne-based IVC practice worked with a Great Workplaces by BVA accreditor during the pilot of the new scheme, to demonstrate its strengths against an accreditation framework covering four key themes: health and wellbeing, leadership and management, culture and learning and development.
In the report, the accreditor was particularly impressed by the practice’s strong leadership and management; its emphasis on accommodating flexibility for team members in various forms; a robust teamworking ethos; and a focus on continuous improvement.
British Veterinary Association President Elizabeth Mullineaux said: “We’re delighted to see Swadlincote Veterinary Centre become the first veterinary workplace to achieve Gold accreditation through Great Workplaces by BVA scheme.
"Congratulations to the whole practice team for this incredible recognition.
“Creating positive working environments and targeting areas for improvement are the key to tackling ongoing workforce challenges around recruitment and retention.
"We hope this first Gold accreditation inspires others to strive towards gaining recognition as workplaces where vet teams thrive.”
Ingrid Stevenson, Clinical Director at Swadlincote Veterinary Centre, said: “While we knew the practice was doing well, we didn’t go into this process expecting Gold at all.
"My practice manager and I were just both really keen to get some feedback and to find out what more we could do to help the team.
“We have several clinical accreditations in the practice, but it is the team that are responsible for achieving these and maintaining the high standards.
"I believe the team should be looked after, recognised and rewarded for their hard work and going above and beyond when necessary.
"The team were really pleased when I shared the news.
"It has certainly been good for team morale and a positive outcome to share with potential new recruits. '
“The accreditation process was a thorough assessment of the practice and our accreditor made us feel all at ease during the interviews.
"While we achieved Gold, which was unexpected, we have also learnt of areas to develop further over the coming months.
"Overall, it was a positive experience for our practice.”
www.bva.co.uk/take-action/good-veterinary-workplaces/
Anyone - clients, colleagues or mentors - can nominate a young vet who they think has exceptional clinical skills, a particular passion for equine welfare or great leadership skills.
To be eligible nominees need to be members of BEVA, have graduated within the past seven years and be a registered professional with the appropriate body (eg RCVS).
BEVA Council Member Gemma Dransfield said: “We all know that one superstar who's brilliant with patients, fantastic with clients, and just an all-round legend in the making."
“This is your chance to give them the recognition they deserve.
"The BEVA One To Watch Award recognises those who are shaping the future, setting new standards in equine care, and driving the next generation of equine veterinary excellence.
"Not only will they have the glowing accolade of winning, but they will also win some career-boosting perks.”
To put an individual forward for consideration, a seconder is needed and either the nominator or seconder must be a BEVA member.
All nominations will be reviewed by a panel of experts comprising a BEVA Careers Committee representative, a senior equine vet, a non-equine veterinary professional and an external industry representative or client.
Up to five finalists will be selected and invited for a friendly online chat with the judging panel.
The winner will be announced at BEVA Congress and will be presented with a trophy, one year of BEVA membership, a fully paid BEVA Congress experience (including a one-day pass, overnight stay, and ticket to the annual dinner) and an exclusive career-boosting opportunities with BEVA to help take their career to the next level.
All finalists will receive a one-day ticket to BEVA Congress.
www.beva.org.uk/About-us/What-we-do/BEVA-Awards/One-to-watch